Improving Sexual Function in Postmenopausal Women

Article

How much does ospemifene really help in the improvement of sexual function in postmenopausal women? David Portman, MD, discusses new study findings.

After menopause, some women are distressed about their inability to enjoy sex or their avoidance of intimate acts because they know it will be painful, thanks to a loss of estrogen and its effect on vulvar and vaginal tissues. Ospemifene has been approved for the treatment of dyspareunia, or painful sex, in postmenopausal women. But what kind of effect does it have on hormone levels, and how much relief does this treatment really offer?

In this video, David Portman, MD, of the Columbus Center for Women's Health Research, Columbus, Ohio, discusses what he's learned through new research on the drug and how it relates to improvement in sexual function in postmenopausal women.

This research was presented last month at the 25th Annual Meeting of The North American Menopause Society.

Related Videos
Why doxycycline PEP lacks clinical data for STI prevention in women
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
Revolutionizing menopause management: A deep dive into fezolinetant | Image Credit: uvahealth.com.
How to address sexual dysfunction during menopause | Image Credit: health.usnews.com
Hot flashes poorly impact sleep quality | Image Credit: intimmedicine.com
What's new in endometrium care? | Image Credit: nyulangone.org
How to manage bone health in midlife women | Image Credit: - endocrine.org
Mary Jane Minkin, MD, discusses The Menopause Society 2023 Annual Meeting | Image Credit: Yale School of Medicine
Highlights from The Menopause Society 2023 Annual Meeting  | Image Credit: nursebarb.com
How fezolinetant changes management of hot flashes | Image Credit: medschool.cuanschutz.edu.
Related Content
© 2024 MJH Life Sciences

All rights reserved.